# Wound Additives in Primary Total Joint Athroplasty

> **NCT03158623** · PHASE3 · COMPLETED · sponsor: **Salt Lake Orthopedic Clinic** · enrollment: 90 (actual)

## Conditions studied

- Arthroplasty, Replacement

## Interventions

- **BIOLOGICAL:** Platelet Rich Plasma
- **BIOLOGICAL:** Cellerate

## Key facts

- **NCT ID:** NCT03158623
- **Lead sponsor:** Salt Lake Orthopedic Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-01
- **Primary completion:** 2016-12-06
- **Final completion:** 2016-12-20
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2017-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03158623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03158623, "Wound Additives in Primary Total Joint Athroplasty". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03158623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*